BREAKING: Dow Drops; On Pace For Weekly Loss
Energy stocks like Cactus (WHD) have taken a wild ride this year, soaring after Russia invaded Ukraine, then falling in the last couple of months as oil and gas companies ramp up production. Houston-based Cactus went along for the ride, posting quarterly sales increases ranging from 56% to 93% over the past year. On Wednesday, Cactus stock's Relative Strength (RS) Rating climbed from 78 the day before to 82.
Cactus makes and sells wellheads and pressure control equipment to oil and gas companies.
The new 82 RS Rating is an indication that Cactus stock still has some gas in its tank. Market research shows that the market's biggest winners tend to have an RS Rating of at least 80 in the early stages of their moves.
Looking For Winning Stocks? Try This Simple Routine
Among its other key ratings small-cap Cactus has an 82 EPS Rating, of 99. Cactus stock carries an 88 Composite Rating, putting it in the top 12% of stocks on a group of five other key ratings. It has an outstanding A SMR Rating (Sales growth+profit Margins+Return on equity). One yellow flag — it has an E Accumulation/Distribution Rating, which shows that institutional investors aren't on board yet.
Cactus stock hit an all-time high 64.18 on March 11 then consolidated. It fell to 34.85 on July 21 then began rising. Wednesday afternoon Cactus traded around 47, up about 5% for the day. Look for Cactus to form a fresh base such as a cup with handle or three weeks tight.
Earnings shot up 175% last quarter to 44 cents per share. It was its third quarter in a row of triple-digit sales growth. Revenue climbed 56% to $170 million. The prior three stanzas its revenue grew 93%, 91% and 73%.
Cactus stock holds the No. 6 rank among its peers in the Oil & Gas-Machinery/Equipment industry group. DistributionNow (DNOW) and Forum Energy Technology (FET) are also among the group's highest-rated stocks.
When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.
IBD's unique RS Rating measures market leadership by showing how a stock's price movement over the last 52 weeks measures up against that of the other stocks in our database.
Get these newsletters delivered to your inbox & more info about our products & services. Privacy Policy & Terms of Use
Please follow James DeTar on Twitter @JimDeTar
Why Should You Use IBD's Relative Strength Rating?
IBD Live: A New Tool For Daily Stock Market Analysis
How Relative Strength Line Can Help You Judge A Stock
Evaluate Any Stock With Stock Ratings, IBD Charts And Stock Checkup
Find Winning Stocks With MarketSmith Pattern Recognition & Custom Screens
9/12/2022 Cactus shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
9/12/2022 Cactus shows rising price performance, earning an upgrade to its...
Biotechs are making remarkable strides in clinical testing, and biotech stocks are outperforming the rest of the market. (© Chris Gash)
Get instant access to exclusive stock lists, expert market analysis and powerful tools with 2 months of IBD Digital for only $20!
Get market updates, educational videos, webinars, and stock analysis.
Learn how you can make more money with IBD's investing tools, top-performing stock lists, and educational content.
Notice: Information contained herein is not and should not be construed as an offer, solicitation, or recommendation to buy or sell securities. The information has been obtained from sources we believe to be reliable; however no guarantee is made or implied with respect to its accuracy, timeliness, or completeness. Authors may own the stocks they discuss. The information and content are subject to change without notice.
*Real-time prices by Nasdaq Last Sale. Realtime quote and/or trade prices are not sourced from all markets.
Ownership data provided by Refinitiv and Estimates data provided by FactSet.
© 2000-2022 Investor's Business Daily, LLC. All rights reserved